Concepedia

Pavla Kriz

PK

Statistics

Publications

10

Citations

1.5K

H-Index

10

Active since

2004

Affiliations

National Institute of Public Health(Current)

University of Defence

GlaxoSmithKline (Belgium)

GlaxoSmithKline (United Kingdom)

Czech Academy of Sciences, Institute of Microbiology

Pavla Kriz is an author at National Institute of Public Health specializing in infectious diseases, bacterial infections, and immunization.

Publications per year

2004–2011

10

Publications

10

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

Roman Prymula, Pascal Peeters, Viktor Chrobok et al. · The Lancet · 2006 · 640 citations

, , +16

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both <i>Streptococcus pneumoniae</i> and non‐typable <i>Haemophilus influenzae</i>: a randomised double‐blind efficacy study

Roman Prymula, Pascal Peeters, Viktor Chrobok et al. · Clinical Otolaryngology · 2006 · 523 citations

, , +16

Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age

Roman Prymula, Pavla Kriz, Eva Kaliskova et al. · Vaccine · 2009 · 87 citations

, , +17

Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage

Roman Prymula, I Hanovcová, Miroslav Špliňo et al. · Vaccine · 2011 · 71 citations

, , +12

Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics

Jan Poolman, Pavla Kriz, Christiane Feron et al. · Vaccine · 2009 · 66 citations

, , +15

1–5 of 10